Nurix Therapeutics, Inc. (NRIX)

Nurix Therapeutics Revenue

Nurix Therapeutics had revenue of $18.45M in the quarter ending February 28, 2025, with 11.26% growth. This brings the company's revenue in the last twelve months to $56.42M, down -30.25% year-over-year. In the fiscal year ending November 30, 2024, Nurix Therapeutics had annual revenue of $54.55M, down -29.15%.

• Revenue (ttm): $56.42M
• Revenue Growth: -30.25%
• P/S Ratio: 15.10
• Revenue / Employee: $197,262
• Employees: 286
• Market Cap: 872.14M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Nov 30, 2024	54.55M	-22.44M	-29.15%
Nov 30, 2023	76.99M	38.36M	99.31%
Nov 30, 2022	38.63M	8.88M	29.84%
Nov 30, 2021	29.75M	11.93M	66.95%
Nov 30, 2020	17.82M	-13.30M	-42.73%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.